Suvoda unveils major platform release unifying study data, patient engagement, and trial operations. Suvoda, a Conshohocken, Pennsylvania-based global clinical trial technology company, announced on September 30, 2026 a new platform release marking its most significant set of advancements since unifying the Suvoda and Greenphire product lines onto a single platform following their merger. The release addresses a longstanding clinical trial challenge: study teams historically had to stitch together disconnected vendor tools - separate logins, support teams, and systems - to manage randomization, drug supply, questionnaire completion, payments, travel, and patient consent. CEO Jagath Wanninayake said: "This release shows what a platform-based and AI-enabled product suite makes possible. Sites can spend less time reconciling systems, patients can have an easier clinical trial experience wherever they are, and sponsors get faster answers to their important questions. I'm immensely proud of our teams. They have embraced a bold vision for the future and have brought it to life through innovative technology designed to make clinical trial work better for everyone involved." AI built directly into the platform. Suvoda is rolling out AI capabilities across the unified platform, starting with RTSM and eCOA and expanding into financial services like patient payments. The company says its agentic RTSM capability is demonstrating up to an 80% reduction in kickoff-to-UAT timelines, while Sofia, Suvoda's conversational AI assistant, lets sponsors and sites find information and take permissioned action across multiple languages - with every action logged, auditable, and still subject to human sign-off authority at each step. A new Product Launchpad, rolling out across global trials, lets study teams move between RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Site Payments, and Budgeting & Benchmarking without switching systems. A unified data layer means participant data entered once in RTSM flows automatically across the other products, eliminating manual re-entry. New reporting and self-service tools - including a finance and travel reporting portal and an in-platform negotiation feature for Budgeting & Benchmarking - are meant to give sponsors and CROs faster, more confident access to study data, with payment data feeding back in real time to sharpen fair-market-value benchmarks. A smoother experience for patients and sites. The Suvoda App now gives patients a single place to track visits, book rides, complete questionnaires, and receive micropayments upon task completion, while sites can conduct video calls for at-home visits and share scheduling availability directly. Patients can be reimbursed through the payment method that works for them, including digital wallets such as Alipay in China - reducing inbound calls and manual handoffs for sites managing payment and travel status. About Suvoda. Suvoda is a global clinical trial technology company delivering interconnected, action-driven software and services for mission-critical, time-sensitive clinical trial moments. The company's platform supports more than 6,000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. Stay in the loop. You'll get news for your region. Change topics or unsubscribe from any email.

Suvoda, a global clinical trial technology company, has announced a major platform release following its merger with Greenphire. The unified platform integrates eight products including RTSM/IRT, eCOA, eConsent, scheduling, and payment systems under one login. Key features include AI capabilities that demonstrate up to 80% reduction in kickoff-to-UAT timelines for RTSM. Sofia, the company's conversational AI assistant, supports multiple languages whilst maintaining human oversight and audit trails. The platform eliminates the need for study teams to manage separate vendors and logins. A unified data layer allows participant information to flow automatically between products, reducing manual data entry. Patients can access a single app to track visits, complete questionnaires, and receive payments through preferred methods, including digital wallets like Alipay in China. Sites benefit from reduced administrative work and improved scheduling capabilities. The platform aims to streamline clinical trial operations for sponsors, CROs, sites, and patients globally.

Suvoda earns two PM360 Innovation Awards for Sofia AI assistant and Suvoda App. September 16, 2026 at 13:30 PM EDT i This article is third-party content and does not represent the views of this site. Tamar Securities, LLC make no guarantees regarding its accuracy or completeness. CONSHOHOCKEN, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) - Suvoda, a global clinical trial technology company, today announced that PM360 has named the company a winner of two 2026 Innovation Awards: Sofia, Suvoda's AI assistant, in the Artificial Intelligence category, and the Suvoda App in the Clinical Trials category. Both innovations will be featured in PM360's September issue. For Suvoda, the recognition acknowledges its focus on reducing the burdens that people encounter at different points in a clinical trial: patients managing visits, questionnaires, travel, and reimbursement alongside the demands of daily life; site teams tracking study status, drug supplies, and participant needs; and sponsors coordinating complex studies where delays and disconnected information can slow decisions. Suvoda built Sofia and the Suvoda App to address those burdens. Sofia: a conversational AI assistant built for regulated trials Sofia gives study teams faster access to the RTSM study data and eCOA information they need to understand what is happening in a trial and take the next step. Through a conversational interface, sponsors can chat with Sofia to gain insights into drug inventory, access reports, and understand the latest trial status, helping them make confident decisions. Sites can get fast answers to common questions about their trial, so they can spend less time navigating the system and more time advancing the trial. Sofia provides clear, contextual answers, accompanied by relevant tables and visualizations. Suvoda built Sofia with guardrails designed to constrain responses to tested, study-specific information while keeping answers auditable and enforcing role-based access and data privacy controls. For example, Sofia applies each user's role, permissions, and study context while maintaining study blinding and data integrity. Sofia can respond to questions across more than 40 topics, with deterministic instructions and fully validated responses. It runs on the Suvoda Platform, which has supported more than 6,000 trials across more than 115 countries. "Clinical trial teams need fast, clear answers to the questions that come up every day," said Jadon Sargeant, Senior Product Owner at Suvoda. "With Sofia, we're putting that information closer to the moment a decision needs to be made. This recognition reflects the care we've taken to make AI useful in a highly regulated industry, staying grounded in study context, permissions, and thorough testing." Suvoda App: one place for the patients' study needs The Suvoda App gives patients more control over their clinical trial experience by bringing several tasks into one mobile experience. Instead of navigating separate tools, emails, and phone calls, patients can complete questionnaires and diaries, submit receipts, track reimbursement status, book a rideshare, view travel details, schedule and reschedule visits, and receive important reminders in one place. "Participating in a clinical trial is already a lot to ask of someone," said Elizabeth Smith, Director of Product Management, Patient Engagement at Suvoda. "The Suvoda App brings together many activities which have historically been separate and confusing. Now patients can see what they need to do next and take care of everything in one place. This award reflects that we listened when patients and sites told us how their experiences could be simpler." Together, Sofia and the Suvoda App reflect Suvoda's ambition to build technology that eases the experience for the people doing the hard, essential work in clinical trials, so that life-changing studies can keep moving forward. For the past 13 years, PM360's Innovation Issue has highlighted advancements across life sciences and healthcare. PM360 describes itself as the premier magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Innovation Award submissions are judged by PM360's editorial department, with selected innovations featured in the publication's Innovation Issue. About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 6,000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn. Media Contact: Robin Abadía Director, External Communications, Suvoda [email protected] Report this content If you believe this article contains misleading, harmful, or spam content, please let Tamar Securities, LLC know.